Zim Laboratories (NSE:ZIMLAB) Institutional Ownership: 0.01% (As of Jul. 04, 2026)


NSE:ZIMLAB Zim Laboratories Ltd NSE:ZIMLAB
78 GF Score
Price ₹122.01
GF Value ₹102.81
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Zim Laboratories Institutional Ownership?

Zim Laboratories NSE:ZIMLAB -2.00% 78 Institutional Ownership is 0.01% as of Jul. 04, 2026. GuruFocus rates NSE:ZIMLAB with a GF Score™ of 78/100 and a GF Value™ of ₹102.81 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zim Laboratories's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zim Laboratories's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zim Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.

Zim Laboratories Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Zim Laboratories's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zim Laboratories Institutional Ownership Chart

Zim Laboratories Historical Data

The historical data trend for Zim Laboratories can be seen below:

2025-01-31 2025-03-31 2025-04-30
Institutional Ownership 0.01 0.01 0.01
NSE:ZIMLAB
78GF Score
Zim Laboratories Ltd NSE:ZIMLAB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zim Laboratories Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.01% mean?
Zim Laboratories (NSE:ZIMLAB) has a Institutional Ownership of 0.01% as of Jul. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zim Laboratories and its competitors.
Is Zim Laboratories' Institutional Ownership too high?
Zim Laboratories' current Institutional Ownership is 0.01%. Overall, Zim Laboratories has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zim Laboratories' Institutional Ownership compare to ZTS and UTHR?
Zim Laboratories' Institutional Ownership of 0.01% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zim Laboratories and its competitors. Zim Laboratories's current Institutional Ownership is 0.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zim Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Zim Laboratories (NSE:ZIMLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹102.81, compared to a current price of ₹122.01 — trading 18.7% above its estimated fair value. The current Institutional Ownership is 0.01%. Zim Laboratories' overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Zim Laboratories (NSE:ZIMLAB), the current Institutional Ownership is 0.01% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zim Laboratories (NSE:ZIMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Zim Laboratories stock appears to be overvalued. The current stock price of ₹122.01 is trading 18.7% above its estimated GF Value™ of ₹102.81. GuruFocus considers Zim Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:ZIMLAB:

  • Institutional Ownership: 0.01%
  • GF Value™: ₹102.81 vs. price of ₹122.01 (18.7% above fair value)
  • GF Score™: 78/100 with 8 warning signs

No single metric tells the full story. See the NSE:ZIMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zim Laboratories Business Description

Other Exchanges 541400:India
Address Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013
Zim Laboratories Ltd is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. It is engaged in manufacturing &wholesale of pharmaceutical products, market research and research & development activities. The Group is mainly engaged in the business of pharmaceuticals. It has presence in India and Outside India. The company generates majority of revenue from India. Its products are Oral Thin Films, Pre-formulations Intermediates, Finished Formulations.
78GF Score

Get the complete analysis for NSE:ZIMLAB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹122.01
Price
₹102.81
GF Value